Focus on Pharma: Biophysical Characterization of an RSV Antigen at Low Temperatures

Log in to watch this webinar

¿Olvidó su contraseña?
Not registered yet? Create an account
00:00:00 Welcome
00:02:45 Biophysical Characterization of an RSV Antigen at Low Temperatures
00:04:45 Funding and Conflict of Interest Statement
00:05:32 Overview
00:06:29 Untitled
00:06:34 Respiratory Syncytial Virus (RSV)
00:10:15 RSV
00:11:40 RSVA Storage Conditions
00:13:39 SEC-Fabshift Assay of RSV Antigen (RSVA)
00:16:28 SEC-Fabshift Assay of RSV Antigen (RSVA)
00:17:12 Untitled
00:17:19 Near UV Circular Dichroism of RSVA
00:18:46 Far UV Circular Dichroism of RSVA
00:19:23 Sedimentation Velocity of RSVA
00:21:30 Summary Physical Characterization
00:22:22 Differential Scanning Calorimetry of RSVA
00:23:04 Differential Scanning Calorimetry of RSVA
00:23:22 Differential Scanning Calorimetry of RSVA
00:23:33 Differential Scanning Calorimetry of RSVA
00:23:44 Differential Scanning Calorimetry of RSVA
00:25:59 DSC of RSVA Transition A with Urea
00:27:24 Extrapolation of ΔG°unfolding for Transition A
00:28:49 Temperature, Far UV Circular Dichroism
00:29:33 Thermodynamic Characterization Summary
00:30:15 Thank you
00:30:27 Question & Answers

Respiratory Syncytial Virus (RSV) infects millions of people each year causing disease in the lungs and respiratory tract. For individuals with developing or compromised immune systems (such as infants or older adults), RSV infection can result in hospitalization or death. Proteins on the surface of the viral membrane can be targeted by the adaptive immune system. Furthermore, their function is critical to viral infection making them an attractive potential candidate for vaccine development. Of particular interest is the thermostability of an antigen at low temperatures in liquid formulation because it has been observed that the antigen exhibits reduced in vitro potency of a critical epitope more quickly when stored at 5 °C than 25 °C.

To understand this phenomenon, the physicochemical properties were assessed. The Gibbs free energy of folding (ΔG°fold) was determined with differential scanning calorimetry and the analysis revealed that the ΔG°fold at 5 °C and 25 °C is -1.2 and -3.5 kcal/mol, respectively. This result provides a biophysical explanation for the apparent cold denaturation, because the antigen gains approximately 2 kcal/mol in ΔG°fold when stored at 25 °C versus 5 °C. In order to understand the structural aspects of the instability at low temperature, an investigation was initiated to determine how the secondary structure, tertiary structure , and hydrodynamic radius of the antigen were affected. The results of the investigation revealed that the secondary structure was maintained, the tertiary structure was not preserved, and the hydrodynamic radius decreased. This study provides further detail into the physicochemical characteristics of the antigen as a vaccine candidate and deepens our understanding of its design limits.


Guest Presenter: Matthew Scholfield (M.R.S.) - GSK Slaoui Center for Vaccines Research
Authors of the work to be presented:
Matthew R. Scholfield (M.R.S.)*†, Ratnesh Pandey (R.P.)*†, Ronald T. Toth IV (R.T.T.)*, Eric J. Yearley (E.J.Y), Sarita Acharya*(S.A.), Nicolas Moniotte (N.M.)*, Adora Padilla (A.P.)*, Zihao Wang (Z.W.)*, Kunal Bakshi (K.B.)*
*Slaoui Center for Vaccines Research, GSK, 14200 Shady Grove Rd. Rockville, MD 20850
†Authors contributed equally to the research contained in this article.

Más información

  • What will you learn?

- Physical stability of biologics, including vaccines, is a critical factor impacting product quality, potency and storage conditions.

- Detailed and robust characterization by complementary and orthogonal analytics is employed to profile stability of biologics and to study and address mechanisms of degradation.

- Differential Scanning Calorimetry (DSC) is one of the key biophysical techniques used for detailed characterization of thermal stability of biologics.

- DSC provides first principle physicochemical characteristics of thermal unfolding of a protein, such as vaccine antigen, and, along with complementary data on structure and homogeneity in solution, informs protein engineering and supports process and formulation development.